- Nail Changes During Docetaxel Containing Combination Chemotherapy
-
Woo IS, Shim KH, Kim GY, Lee MA, Kang JH, Hong YS, Lee KS
- KMID: 759702
- Korean J Intern Med.
- 2004 Jun;19(2):132-133.
Nail toxicity following systemic chemotherapy is common. Onychopathy during the period of neutropenia following chemotherapy may cause subungual abscesses and serious infection. Despite taxoid-related toxicity being increasingly reported since 2000,... -
- CITED
-
- Close
- SHARE
-
- Close
- Hand-Foot Syndrome with Scleroderma-like Change Induced by the Oral Capecitabine: A Case Report
-
Lee SD, Kim HJ, Hwang SJ, Kim YJ, Nam SH, Kim BS
- KMID: 1091871
- Korean J Intern Med.
- 2007 Jun;22(2):109-112.
- doi: 10.3904/kjim.2007.22.2.109
Hand-foot syndrome (HFS) is a well-known adverse event associated with capecitabine, a prodrug of 5-Fluorouracil (5-FU). HFS manifests as acral erythema, with swelling and dysesthesia of the palms and plantar... -
- CITED
-
- Close
- SHARE
-
- Close
- Change of telomerase activity in rectal cancer with chemoradiation therapy
-
Kim HR, Kim YJ, Kim HJ, Kim SK, Lee JH
- KMID: 648118
- J Korean Med Sci.
- 2000 Apr;15(2):167-172.
- doi: 10.3346/jkms.2000.15.2.167
Telomerase, an enzyme associated with cellular immortality, is expressed by most malignant cells and is inactive in most normal somatic cells, with the exception of proliferative stem cells, germ cells... -
- CITED
-
- Close
- SHARE
-
- Close
- Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma
-
Lee IJ, Kim JW, Han KH, Kim JK, Kim KS, Choi JS, Park YN, Seong J
- KMID: 2070195
- Yonsei Med J.
- 2014 Nov;55(6):1489-1497.
- doi: 10.3349/ymj.2014.55.6.1489
PURPOSE: For locally unresectable hepatocellular carcinoma (HCC) patients, concurrent chemoradiotherapy (CCRT) has been applied as a loco-regional treatment. After shrinkage of tumors in selected patients, surgical resection is performed. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia
-
Park H, Chung H, Lee J, Jang J, Kim Y, Kim SJ, Kim JS, Min YH, Cheong JW
- KMID: 2374186
- Yonsei Med J.
- 2017 Jan;58(1):35-42.
- doi: 10.3349/ymj.2017.58.1.35
PURPOSE: Decitabine, a DNA hypomethylating agent, was recently approved for use in Korea for older adults with acute myeloid leukemia (AML) who are not candidates for standard chemotherapy. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
-
Jung JY, Rha SY, Ahn JB, Yang WI, Noh SH, Chung HC, Jeung HC
- KMID: 1382660
- Korean J Intern Med.
- 2008 Mar;23(1):37-41.
- doi: 10.3904/kjim.2008.23.1.37
S-1, a novel oral fluoropyrimidine, is an effective therapeutic agent for gastric cancer. Herein, we report a case with locally advanced gastric cancer that achieved a curative resection after S-1... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Efficacy of Oral Capecitabine versus Bolus 5-FU in Preoperative Radiotherapy of Locally Advanced Rectal Cancer
-
Kim JS, Kim JS, Cho MJ, Yoon WH, Song KS
- KMID: 2157782
- J Korean Med Sci.
- 2006 Feb;21(1):52-57.
- doi: 10.3346/jkms.2006.21.1.52
The effects of treatment with oral capecitabine vs. bolus 5-FU, administered concurrently with preoperative radiotherapy, were compared in the treatment of locally advanced rectal cancer (LARC). One hundred and twenty-seven... -
- CITED
-
- Close
- SHARE
-
- Close
